. Malignant ovarian Brenner tumor in an 85-year-old woman. Contrast-enhanced computed tomography (CT) shows a unilocular cystic mass with mural solid components. Dense calciˆcation was observed in part of the solid components (arrow).
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Introduction
Ovarian Brenner tumor is an uncommon epithelial tumor that comprises only one to 2z of all ovarian tumors, and only 2 to 5z are malignant. [1] [2] [3] [4] Although computed tomography (CT) and magnetic resonance (MR) imaging features of benign Brenner tumors have been described, [5] [6] [7] reports ofˆnd-ings of borderline and malignant Brenner tumors are limited. [6] [7] [8] [9] Moreover,ˆndings of diŠusion-weighted imaging (DWI) of malignant Brenner tumor are not reported. We report a case of malignant ovarian Brenner tumor with components that transition from benign to malignant, and we correlateˆndings from CT and MR imaging, including DWI, with pathologicalˆndings.
Case Report
An 85-year-old woman, gravida 2, para 2, with a history of total abdominal hysterectomy for uterine leiomyoma at age 35, underwent surgery for cancer of the cecum at our hospital 2 years prior to this report. At routine follow-up examination, contrast-enhanced CT showed a unilocular cystic mass of 9-cm diameter with solid mural components that included dense calciˆcation in the pelvis (Fig. 1) , and we suspected recurrence or ovarian tumor. Biochemistry revealed serum cancer antigen 125 (CA 125) elevated to 241 IU/mL (reference values, º35 IU/mL).
MR imaging showed a unilocular cystic mass with 2 solid mural components. A part of the solid components that originated from its anterior wall contained dense calciˆcations on CT and showed very low signal intensity on T 2 - (Fig. 2a) and T 1 -weighted images (Fig. 2b) . The other parts of the solid components that originated from its right side 
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wall showed slightly high signal intensity with tiny hyperintense spots on T 2 -weighted images ( Fig. 2a ) and high signal intensity on DWI (Fig. 2c) . The apparent diŠusion coe‹cient (ADC) value of the anterior solid component obtained from DWI (b＝0, 1000 s/mm 2 ) was 1.15±0.12×10
-3 mm 2 /s, whereas that of the right solid component was 0.84±0.11× 10 -3 mm 2 /s. Gynecologists performed surgery including right oophorectomy and omentectomy. The tumor originated in the pelvis, replaced the right ovary, and was attached to the greater omentum; macroscopically, it comprised 2 adjacent hard solid areas and one cystic space containing ‰uid. The cut surface of the solid components of the anterior wall was whitish-yellow and hard with calciˆ-cation, and that of the right side wall was whitish yellow with a cavitation (Fig. 3a) . Histologically, the solid component of the anterior wall showed a feature of typical benign Brenner tumor that consisted of transitional cells inˆbrous stroma with hyalinization and calciˆcation (Fig. 3b) . We made a pathological diagnosis of malignant Brenner tumor of the right ovary. The solid area of the right side wall adjacent to the former lesion composed of the solid tumor resembling Brenner tumor with signiˆcant atypia and inˆltrating high-grade poorly diŠerentiated carcinoma (Fig. 3c) . We made a pathological diagnosis of malignant Brenner tumor of the right ovary. Immunohistochemically, both the typical area of Brenner tumor and malignant component were positive for cytokeratin 7 and negative for cytokeratin 20, which was consistent with the immunophenotype of Brenner tumor. Follow-up biochemistry after surgery revealed an elevation of CA-125, from 60 IU/mL following surgery to 128 IU/mL after 3 months, but neither 
Discussion
The current World Health Organization (WHO) classiˆcation of transitional cell tumor of the ovary includes benign Brenner tumor, Brenner tumor of borderline malignancy, malignant Brenner tumor, and transitional cell carcinoma (non-Brenner type). 4 The microscopicˆndings of malignant Brenner tumor show components of malignant transitional cell tumor intermixed with benign and borderline elements, whereas transitional cell carcinoma comprises only malignant elements. 2, 4 Transitional cell carcinoma may be a more aggressive neoplasm than malignant Brenner tumor and tend to present at a higher stage.
Ovarian Brenner tumor is an uncommon epithelial tumor that comprises only one to 2z of all ovarian tumors, and only 2 to 5z are malignant. [1] [2] [3] [4] The entity contains both benign and atypical transitional components. 4 On average, malignant varieties occur 10 years later than benign tumors. Most malignant Brenner tumors spread locoregionally, with fewer than 50z presenting with extrapelvic metastases. 2 The current mainstay of treatment is appropriate surgical staging and cytoreduction, though the e‹cacy of adjuvant chemotherapy and/ or radiation therapy is underestimated. 3 Brenner tumors typically contain both solid and cystic components and often appear as a large cystic tumor with papillary or polypoid nodule in the wall. 4 Several authors have reported that imaging features of benign Brenner tumors include very low signal intensity of the solid component on T 2 -weighted images, which re‰ects denseˆbrous collagen tissues, and CTˆndings of extensive amorphous calciˆcation within the tumors. [5] [6] [7] There have been onlyˆve reports of MR imagingˆndings of borderline or malignant Brenner tumors. [6] [7] [8] [9] All four reports demonstrated that the tumor exhibited a cystic tumor with papillary or polypoid solid component. Although Moon's group 6 described the signal of the solid component on T 2 -weighted images as hypointense, the other four authors reported it as medium to high. Takeuchi and associates 9 demonstrated that the admixture of very low and hyperintense solid components on T 2 -weighted images may well correlate with the transition from benign to malignant Brenner components, which is the pathological feature of malignant Brenner tumors, and may be a diagnostic clue to these rare tumors. The CT and MR imaging appearance of our case and Takeuchi's case were similar.
Moreover, in our case, DWI and ADC value were useful in distinguishing benign from malignant solid component in a malignant Brenner tumor. The benign solid component showed medium ADC value (1.15±0.12×10 -3 mm 2 /s) and low signal intensity on DWI, probably as a consequence of the``T 2 black-out eŠect,'' whereas the malignant solid component showed low ADC value (0.84± 0.11×10 -3 mm 2 /s) and high signal intensity on DWI, re‰ecting higher cellularity. We believe no report has demonstrated the usefulness of DWI and ADC value in diagnosing a malignant Brenner tumor, and their clinical usefulness in discriminating benign from malignant ovarian tumors has been controversial. [10] [11] [12] Takeuchi's team 10 reported a tendency of the ADC of the solid component of malignant/borderline malignant ovarian tumors to be lower than that of benign ovarian tumors, probably because of the higher cellularity and more enlarged nuclei in the malignant/borderline tumor.
Thomassin-Naggara 11 and Fujii 12 and their associates demonstrated that ADC measurement did not contribute to the diŠerentiation of benign from malignant ovarian mass because of the frequently low ADC value of benign ovarian tumors, such aŝ broma,ˆbrothecoma, cystadenoˆbroma, teratoma, and endometrial cyst, and the usually high ADC value of malignant ovarian tumors, such as serous or mucinous borderline malignant tumor and metastatic tumor.
In conclusion, in addition to T 2 -weighted images, DWI and ADC value may be useful in distinguishing malignant from benign solid component in malignant Brenner tumor and may be a diagnostic clue to this rare tumor.
